Compare SLQT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | IRMD |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.3M | 1.1B |
| IPO Year | 2020 | 2014 |
| Metric | SLQT | IRMD |
|---|---|---|
| Price | $0.47 | $82.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.88 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 1.3M | 82.5K |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $1,618,499,000.00 | $83,814,000.00 |
| Revenue This Year | $10.97 | $12.38 |
| Revenue Next Year | $6.14 | $11.31 |
| P/E Ratio | ★ N/A | $96.21 |
| Revenue Growth | 6.02 | ★ 14.43 |
| 52 Week Low | $0.46 | $67.84 |
| 52 Week High | $2.22 | $107.90 |
| Indicator | SLQT | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.52 | 33.55 |
| Support Level | N/A | $82.25 |
| Resistance Level | $0.79 | $88.93 |
| Average True Range (ATR) | 0.03 | 2.01 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 18.24 | 19.55 |
SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.